We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+18.62%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$21B
AUM Growth
+$356M
Cap. Flow
-$1.77B
Cap. Flow %
-8.43%
Top 10 Hldgs %
50.08%
Holding
490
New
56
Increased
118
Reduced
220
Closed
84

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$359M
2
APP icon
Applovin
APP
+$255M
3
NTRA icon
Natera
NTRA
+$145M
4
ALAB icon
Astera Labs
ALAB
+$135M
5
DHR icon
Danaher
DHR
+$122M

Sector Composition

Rank Sector Weight
1 Technology 37.02%
2 Communication Services 15.92%
3 Consumer Discretionary 13.84%
4 Industrials 12.34%
5 Healthcare 10.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
326
Vertex Pharmaceuticals
VRTX
$123B
$2.12M 0.01%
5,262
-12,773
-71% -$5.92M
NAMS icon
327
NewAmsterdam Pharma
NAMS
$3.26B
$2.07M 0.01%
+80,579
New +$1.71M
RPD icon
328
Rapid7
RPD
$628M
$2.03M 0.01%
50,424
-27
-0.1% -$1.09K
MYRG icon
329
MYR Group
MYRG
$5.01B
$2M 0.01%
13,464
-3,047
-18% -$426K
GO icon
330
Grocery Outlet
GO
$904M
$1.99M 0.01%
127,625
-82
-0.1% -$1.43K
MRUS
331
DELISTED
Merus
MRUS
$1.99M 0.01%
47,288
-10,658
-18% -$512K
GAP
332
The Gap Inc
GAP
$7.3B
$1.97M 0.01%
+83,338
New +$1.9M
CRVL icon
333
CorVel
CRVL
$3.18B
$1.93M 0.01%
+17,390
New +$1.95M
MQ icon
334
Marqeta
MQ
$1.93B
$1.91M 0.01%
125,883
+177
+0.1% +$3.11K
DNLI icon
335
Denali Therapeutics
DNLI
$3.79B
$1.87M 0.01%
91,807
-29,509
-24% -$755K
GPCR icon
336
Structure Therapeutics
GPCR
$3.37B
$1.81M 0.01%
66,662
-51
-0.1% -$1.81K
RDNT icon
337
RadNet
RDNT
$4.98B
$1.78M 0.01%
+25,503
New +$1.88M
ORIC icon
338
Oric Pharmaceuticals
ORIC
$1.17B
$1.77M 0.01%
219,276
-171
-0.1% -$1.57K
CRM icon
339
Salesforce
CRM
$154B
$1.76M 0.01%
5,270
-379
-7% -$121K
MCK icon
340
McKesson
MCK
$104B
$1.76M 0.01%
3,091
+1,510
+96% +$846K
TRMB icon
341
Trimble
TRMB
$13.6B
$1.75M 0.01%
24,717
+18,796
+317% +$1.28M
BMRN icon
342
BioMarin Pharmaceuticals
BMRN
$11.9B
$1.7M 0.01%
25,870
-703
-3% -$47.1K
SRRK icon
343
Scholar Rock
SRRK
$5.88B
$1.65M 0.01%
+38,172
New +$1.24M
MXCT icon
344
MaxCyte
MXCT
$108M
$1.62M 0.01%
389,435
-183
-0% -$692
PEP icon
345
PepsiCo
PEP
$196B
$1.61M 0.01%
10,512
-39,919
-79% -$6.54M
HQY icon
346
HealthEquity
HQY
$8.71B
$1.58M 0.01%
+16,497
New +$1.54M
CBLL
347
CeriBell Inc
CBLL
$673M
$1.57M 0.01%
+60,761
New +$1.66M
BCPC
348
Balchem Corp
BCPC
$5.26B
$1.52M 0.01%
9,267
GSK icon
349
GSK
GSK
$107B
$1.52M 0.01%
44,303
-498
-1% -$17.9K
EHC icon
350
Encompass Health
EHC
$11.3B
$1.46M 0.01%
15,837
-14,804
-48% -$1.45M

Similar funds

Fred Alger Management's Q4 2024 Portfolio in Review

As of Q4 2024, Fred Alger Management held 490 positions worth $21B, up 1.7% from $20.6B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Fred Alger Management withdrew a net $1.77B in Q4 2024, closing 84 positions and reducing 220 holdings. Its most notable exit was TSMC, an estimated $359M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 38% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Fred Alger Management opened a new position in Nebius Group N.V. worth $155M.

  • Fred Alger Management's largest Q4 2024 buy was Nebius Group N.V.: 5,588,985 shares worth $155M.
  • Fred Alger Management added most to Tesla in Q4 2024, an estimated $146M increase.
  • Fred Alger Management's biggest Q4 2024 reduction was Applovin, cutting an estimated $255M.
  • Fred Alger Management fully exited TSMC in Q4 2024, selling an estimated $359M.
  • Fred Alger Management's ten largest holdings make up 50% of its $21B portfolio in Q4 2024.
  • Fred Alger Management opened 56 new positions and closed 84 in Q4 2024.
  • Fred Alger Management's portfolio value rose 1.7% quarter-over-quarter to $21B.

Based on Fred Alger Management's 13F filing for Q4 2024, filed 14 Feb 2025.